Literature DB >> 24055526

Novel candidate genes for 46,XY gonadal dysgenesis identified by a customized 1 M array-CGH platform.

Ameli Norling1, Angelica Lindén Hirschberg, Erik Iwarsson, Bengt Persson, Anna Wedell, Michela Barbaro.   

Abstract

Half of all patients with a disorder of sex development (DSD) do not receive a specific molecular diagnosis. Comparative genomic hybridization (CGH) can detect copy number changes causing gene haploinsufficiency or over-expression that can lead to impaired gonadal development and gonadal DSD. The purpose of this study was to identify novel candidate genes for 46,XY gonadal dysgenesis (GD) using a customized 1 M array-CGH platform with whole-genome coverage and probe enrichment targeting 78 genes involved in sex development. Fourteen patients with 46,XY gonadal DSD were enrolled in the study. Nine individuals were analyzed by array CGH. All patients were included in a follow up sequencing study of candidate genes. Three novel candidate regions for 46,XY GD were identified in two patients. An interstitial duplication of the SUPT3H gene and a deletion of C2ORF80 were detected in a pair of affected siblings. Sequence analysis of these genes in all patients revealed no additional mutations. A large duplication highlighting PIP5K1B, PRKACG and FAM189A2 as candidates for 46,XY GD, were also detected. All five genes are expressed in testicular tissues, and one is shown to cause gonadal DSD in mice. However detailed functional information is lacking for these genes.
Copyright © 2013 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Array-CGH; C2ORF80; Disorders of sex development; Gonadal dysgenesis; PIP5K1B; SUPT3H

Mesh:

Substances:

Year:  2013        PMID: 24055526     DOI: 10.1016/j.ejmg.2013.09.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

Review 1.  Disorders of sex development: effect of molecular diagnostics.

Authors:  John C Achermann; Sorahia Domenice; Tania A S S Bachega; Mirian Y Nishi; Berenice B Mendonca
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

2.  Gene dosage effects in 46, XY DSD: usefulness of CGH technologies for diagnosis.

Authors:  S Jaillard; A Bashamboo; L Pasquier; M A Belaud-Rotureau; K McElreavey; S Odent; Célia Ravel
Journal:  J Assist Reprod Genet       Date:  2014-11-12       Impact factor: 3.412

3.  Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation.

Authors:  Y Nakamura; H Kayano; E Kakegawa; H Miyazaki; T Nagai; Y Uchida; Y Ito; N Wakimoto; S Mori; M Bessho
Journal:  Blood Cancer J       Date:  2015-04-10       Impact factor: 11.037

Review 4.  New insights into the genetic basis of infertility.

Authors:  Thejaswini Venkatesh; Padmanaban S Suresh; Rie Tsutsumi
Journal:  Appl Clin Genet       Date:  2014-12-01

5.  Identification of a duplication within the GDF9 gene and novel candidate genes for primary ovarian insufficiency (POI) by a customized high-resolution array comparative genomic hybridization platform.

Authors:  A Norling; A L Hirschberg; K A Rodriguez-Wallberg; E Iwarsson; A Wedell; M Barbaro
Journal:  Hum Reprod       Date:  2014-06-17       Impact factor: 6.918

6.  Integrated small copy number variations and epigenome maps of disorders of sex development.

Authors:  Ina E Amarillo; Isabelle Nievera; Andrew Hagan; Vishwa Huchthagowder; Jennifer Heeley; Abby Hollander; Joel Koenig; Paul Austin; Ting Wang
Journal:  Hum Genome Var       Date:  2016-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.